Status:
COMPLETED
Study of the Crystallization Inhibition Capacity of the Uric Acid in Urine in a Group of Lithiasic Patients After Intake of a Food Supplement
Lead Sponsor:
Devicare S.L.
Collaborating Sponsors:
Universidad de las Islas Baleares
Conditions:
Lithiasis
Eligibility:
All Genders
18-75 years
Brief Summary
Renal lithiasis affects a wide range of the population, ranging from 4 to 15% according to the population sample studied. Among all stones, it is estimated that uric stones account for between 10 and ...
Detailed Description
Background Urolithiasis is a pathology known since antiquity although they are not known totally the causes of the formation of all the different types of calculus existing As a consequence of this, o...
Eligibility Criteria
Inclusion
- You are over 18 and less than 75 years old
- You have presented a previous episode of objectifiable uric lithiasis
- Presents normouricemia
- Possesses the results of laboratory tests (biochemistry and urine)
- The patient agrees to participate and collaborate in the study
Exclusion
- Active urinary infection
- Allergy to chocolate or theobromine
- Serum creatinine greater than 1.5 mg / dl
- Pregnancy, lactation period (women)
- Intestinal obstruction
- Hyperuricemia
- Treatment with diuretics
- Treatment with allopurinol or febuxostat.
- Congestive heart failure
- Other pharmacological treatments for the prevention of hyperuricemia
- Chronic renal failure
Key Trial Info
Start Date :
September 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 2 2019
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03483532
Start Date
September 6 2017
End Date
December 2 2019
Last Update
July 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Manacor
Manacor, Balearic Islands, Spain, 07500